Startup India Government of India
Le Italus Biotech Private Limited
Le Italus Biotech Private Limited - pharma in Mumbai, Maharashtra, India. Directors, charges & compliance details.
Revenue · FY 2025
₹2.26 Cr
▲ 26% YoY
Net profit · FY 2025
₹1.05 Lakh
Net margin 0.5%
EBITDA · FY 2025
₹3.6 Lakh
EBITDA margin 1.6%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹15 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
3
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Le Italus Biotech Private Limited
Data last updated:
Le Italus Biotech Private Limited is a private limited company based in Mumbai, Maharashtra, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 September 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U33110MH2021PTC368353.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors including Nairveena Premkumar (Managing Director) and Reshma Aravindan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 912 – Techno IT Park Link Road Borivli West, Mumbai, Maharashtra, India – 400092.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.26 Cr, a growth of 26% compared to the previous year. For the same year it recorded a net profit of ₹1.05 Lakh (net margin 0.5%) and EBITDA of ₹3.6 Lakh (EBITDA margin 1.6%). Revenue has grown at a compounded annual rate (CAGR) of 448% over three years.
Le Italus Biotech Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KL-12-0018446).
Company details
CIN U33110MH2021PTC368353
Registration Number 368353
Incorporation Date 28 September 2021
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-KL-12-0018446
Key People
Nairveena Premkumar Managing Director Reshma Aravindan Director Anagha Thazhekelothjayathilakan Director Recognitions & Rankings of Le Italus Biotech
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-KL-12-0018446
Contact details
Le Italus Biotech Private Limited's registered office is in Mumbai, Maharashtra.
- Registered Address912 – Techno IT Park Link Road Borivli West, Mumbai, Maharashtra, India – 400092
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Le Italus Biotech Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Le Italus Biotech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Le Italus Biotech Private Limited, buy the company report.
Financials of Le Italus Biotech Private Limited
FY 2025 filings availableLe Italus Biotech Private Limited reported revenue of ₹2.26 Cr (up 26% YoY) for FY 2025.
Revenue · FY 2025
₹2.26 Cr ▲ 26%
Net profit · FY 2025
₹1.05 Lakh margin 0.5%
EBITDA · FY 2025
₹3.6 Lakh margin 1.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 26%
3 years · compounded
▲ 448%
EBITDA CAGR growth
1 year
▲ 88%
3 years · compounded
▲ 47%
Revenue has grown at a compounded annual rate (CAGR) of 448% over three years, including 26% growth in the latest year. EBITDA rose 88% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹3.6 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹1.05 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.6% | |||
| Net Profit Margin | 0.5% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Le Italus Biotech Private Limited, buy the company report.
Board of directors of Le Italus Biotech Private Limited
Le Italus Biotech has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nairveena Premkumar | Managing Director | 28 Sep 2021 | 5 Years 1 Months | Current |
| Reshma Aravindan | Director | 28 Sep 2021 | 5 Years 1 Months | Current |
| Anagha Thazhekelothjayathilakan | Director | 28 Sep 2021 | 5 Years 1 Months | Current |
Peer comparison
Le Italus Biotech Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Prestigeus Agri Research and Development Private Limited | ₹2.27 Cr (FY 2016) | -46.0% | Karnataka, India | |||
| Jailuxmi Calcium India Private Limited | ₹2.27 Cr (FY 2019) | Radaur, Haryana, India | ||||
| Apriway Healthcare Private Limited | ₹2.27 Cr (FY 2024) | 486.0% | Bhopal, Madhya Pradesh, India | |||
| Srinivasa Industrial and Agro Products Private Limited | ₹2.26 Cr (FY 2024) | -30.0% | Telangana, India | |||
| Spru Products Private Limited | ₹2.26 Cr (FY 2024) | 155.0% | Lucknow, Uttar Pradesh, India | |||
| Le Italus Biotech Private Limitedthis company | ₹2.26 Cr (FY 2025) | ₹1.05 Lakh | 0.5% | 26.0% | Mumbai, Maharashtra, India | |
| Iha Vedic Essentials Private Limited | ₹2.26 Cr (FY 2024) | -51.0% | Gandhinagar, Gujarat, India | |||
| Beeta Surgicals Private Limited | ₹2.26 Cr (FY 2025) | 3.0% | Rajkot, Gujarat, India | |||
| Euploid Pharmaceuticals Private Limited | ₹2.26 Cr (FY 2025) | 276.0% | Bangalore, Karnataka, India | |||
| Sree Vasthu Paints Private Limited | ₹2.26 Cr (FY 2019) | 92.0% | Kancheepuram, Tamil Nadu, India | |||
| Globentis International Private Limited | ₹2.26 Cr (FY 2025) | -7.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Le Italus Biotech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Le Italus Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Le Italus Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Le Italus Biotech Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Le Italus Biotech Private Limited has 3 board changes on record since 2021: 3 appointments. The latest: Anagha Thazhekelothjayathilakan was appointed as Director on 28 Sep 2021.
AGM
Le Italus Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Le Italus Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Appointed
Anagha Thazhekelothjayathilakan was appointed as Director.
Appointed
Nairveena Premkumar was appointed as Managing Director.
Appointed
Reshma Aravindan was appointed as Director.
Incorporation
28 Sep 2021
Le Italus Biotech Private Limited was registered on 28 Sep 2021 with Roc Mumbai I & aged 5 years 1 month as per MCA records.
Frequently asked questions
Le Italus Biotech is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 September 2021 (5+ years old) and is registered under CIN U33110MH2021PTC368353.
Le Italus Biotech has 3 current directors:
- Nairveena Premkumar - Managing Director
- Reshma Aravindan - Director
- Anagha Thazhekelothjayathilakan - Director
The latest financial statements of Le Italus Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Le Italus Biotech is U33110MH2021PTC368353. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Le Italus Biotech was incorporated on 28 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Le Italus Biotech by revenue are Prestigeus Agri Research and Development Private Limited, Jailuxmi Calcium India Private Limited, Apriway Healthcare Private Limited, Srinivasa Industrial and Agro Products Private Limited, Spru Products Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Anagha Thazhekelothjayathilakan was appointed as Director on 28 Sep 2021. Nairveena Premkumar was appointed as Managing Director on 28 Sep 2021. Reshma Aravindan was appointed as Director on 28 Sep 2021.
Yes, Le Italus Biotech is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Le Italus Biotech is registered as a micro enterprise under Udyam registration (number: UDYAM-KL-12-0018446).
The registered office of Le Italus Biotech is at 912 – Techno IT Park Link Road Borivli West, Mumbai, Maharashtra, India – 400092.
Le Italus Biotech operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages